高盛-华润医药(3320.HK):业绩回顾:运营环境承压下上半年业绩保持平稳-China Resources Pharmaceuticals(3320.HK):Earnings Review:Stable 1H despite a challenging operating environment-20260831【6页】

发表回复

后才能评论